Abstract:Introduction: Large Unilocular radiolucent lesions of the jaws often present a dilemma to both, the Oral Pathologist and the Maxillofacial surgeon with regards to their accurate diagnosis as well as their most appropriate treatment modality. A precise identification as to whether the lesion is a cyst or a tumor is imperative before any treatment is instituted. Once the correct diagnosis and likely prognosis are established, a management protocol can be planned which will completely eliminate the lesion, while at the same time, ensure least possible morbidity for the patient, such as pathological jaw fractures, persisting neurological deficits, esthetic deformity, functional debility, recurrence/persistence of the lesion, etc. AIM & OBJECTIVES: To establish the value of Immunohistochemistry (IH) as a Diagnostic marker and Prognostic indicator for extensive Unilocular radiolucent lesions of the jaws. To assess its role as an adjunct to Histopathological Examination (HPE) in distinguishing Odontogenic tumours from the cysts, by identifying the former using IH Tumor Markers; and in aiding in selection of the most appropriate and effective treatment option for each of such ambiguous lesions, based on their prognosis as indicated by the expression of lH Cell Proliferation Markers. Materials and method: Thirty cases of large Unilocular Radiolucent lesions of the jaws (Maxilla/Mandible) were managed over a period of three years. Histopathological examination (HPE) and Immunohistochemical (IH) analysis were carried out of the biopsy specimens in all the cases. Calretinin, an Immunohistochemical Tumor marker, was used to distinguish between Odontogenic cysts and tumours. Ki-67 and Proliferating Cell Nuclear Antigen (PCNA), Immunohistochemical Cell Proliferation markers, provided information on the aggressive potential of the lesions. On the basis of the above information, an appropriate management protocol was established for each of these different lesions. Nerve sparing enucleation and curettage was employed for the established cases of Odontogenic Cysts; Enucleation and curettage, peripheral ostectomy, followed by chemical cauterization was employed for the Unicystic Ameloblastomas and other Odontogenic tumours with a low Ki-67 and PCNA Proliferation Index (PI)/Labelling index (LI ≤ 3); Marginal resection was carried out for the tumours with a higher Labelling Index (LI >3 ≤5), and Segmental resection (including partial/complete Maxillectomy, Hemimandibulectomy with/without disarticulation) for the aggressive pathologies with high Labelling Index (LI > 5). Results: Of the thirty cases of large Unilocular radiolucent lesions of the Maxilla and Mandible, thirteen were diagnosed as Dentigerous cysts, one as Dentigerous cyst showing Ameloblastomatous transformation; two as Unicystic Ameloblastomas, one as the Mural variant of Unicystic Ameloblastoma; four as Follicular Ameloblastomas, two as Plexiform Ameloblastomas; four as Acanthomatous Ameloblastomas; one as Ameloblastic Fibroma and two as Adenomatoid Odontogenic Tumours. The predictive and prognostic indication of the Immunohistochemical markers correlated well with the post treatment findings. Conclusion: In cases of extensive Unilocular lesions of the jaws, where ambiguity often exists in both diagnosis and appropriate treatment plan to be employed, Immunohistochemistry can serve as an invaluable tool in establishing the precise diagnosis, guiding the treatment plan, as well as indicating the likely prognosis of these lesions.

Conventional ameloblastomas proliferation index vs clinicoradiologic features

A radiologic-pathologic study of the histopathologic variants of ameloblastomas and their proliferation indices

Clinicoradiologic features of ameloblastomas: A single‐centre study of 155 cases

Prognostic and Proliferative Evaluation of Ameloblastoma Based on Radiographic Boundary

[Expression of Ki-67 Antigen in Ameloblastoma and Its Clinical Significance].

Surrogate Immunohistochemical Markers of Proliferation and Embryonic Stem Cells in Distinguishing Ameloblastoma from Ameloblastic Carcinoma

Expression of P21~(waf1), P27~(kip1) and Cyclin E in Ameloblastoma

Expression and Significance of P63, Bcl-2, PCNA, Ki-67 and MCM2 in Ameloblastoma

Correlation Between Imaging Features and Epithelial Cell Proliferation in Keratocystic Odontogenic Tumour.

Soft Tissue Recurrent Ameloblastomas Also Show Some Malignant Features: A Clinicopathological Study of a 15-Year Database.

Clinicopathological study on 322 cases of ameloblastoma

Clinical and Radiologic Features of Desmoplastic Ameloblastoma.

Clinicopathologic Study on a Rare Variant of Ameloblastoma with Basal Cell Features.

Proliferating Activity and Differentiation Between Peripheral Cells and Central Cells in Ameloblastoma

DNA content and clinicopathological features aid in distinguishing ameloblastic carcinoma from ameloblastoma

Ameloblastic carcinoma: A systematic review

[Computed tomographic features of desmoplastic ameloblastoma of the jaw].

3d Cone Beam Computed Tomography Reconstruction Images In Diagnosis Of Ameloblastomas Of Lower Jaw: A Case Report And Mini Review

The efficacy of CBCT-based radiomics techniques in differentiating between conventional and unicystic ameloblastoma

The dilemma of extensive unilocular radiolucent lesions of the jaws - value of immunohistochemistry as a diagnostic marker and prognostic Indicator

3D Cone Beam Computed Tomography Reconstruction Images in Diagnosis of Ameloblastomas of Lower Jaw: A Case Report and Mini Review.